EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Residual Invasive Disease After Neoadjuvant Therapy in Triple-Negative Breast Cancer: Risk Stratification and Postoperative Radiotherapy–Pembrolizumab Integration

Xinyu Jia iD, Eerdemutu, Yuan Ren, Shiduo Yang iD, Chang Yang, Qiaochu Ding, Yu Lin

Cancer Management and Research · 2026-10 · Volume 18 · 1-18

DOI: 10.2147/cmar.s653901 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Management and Research, 2026-10. Verfasst von Xinyu Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Inner Mongolia Medical University, Hohhot, Inner Mongolia, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

neoadjuvant therapypembrolizumabradiotherapyresidual invasive diseaserisk stratificationtriple-negative breast cancer

Autor:innen und Institutionen

  • First Clinical Medical College, Inner Mongolia Medical University, Hohhot, Inner Mongolia, People's Republic of China.
  • Department of Radiation Oncology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, People's Republic of China.

ORCID-Profile: Xinyu Jia, Shiduo Yang

Zitieren

APA

Jia, X., Eerdemutu, Ren, Y., Yang, S., Yang, C., Ding, Q., & Lin, Y. (2026). Residual Invasive Disease After Neoadjuvant Therapy in Triple-Negative Breast Cancer: Risk Stratification and Postoperative Radiotherapy–Pembrolizumab Integration. Cancer Management and Research, Volume 18, 1-18. https://doi.org/10.2147/cmar.s653901

Vancouver

Jia X, Eerdemutu, Ren Y, Yang S, Yang C, Ding Q, et al. Residual Invasive Disease After Neoadjuvant Therapy in Triple-Negative Breast Cancer: Risk Stratification and Postoperative Radiotherapy–Pembrolizumab Integration. Cancer Management and Research. 2026;Volume 18:1-18. doi:10.2147/cmar.s653901

BibTeX
@article{Jia2026,
  author = {Jia, Xinyu and Eerdemutu and Ren, Yuan and Yang, Shiduo and Yang, Chang and Ding, Qiaochu and Lin, Yu},
  title = {Residual Invasive Disease After Neoadjuvant Therapy in Triple-Negative Breast Cancer: Risk Stratification and Postoperative Radiotherapy–Pembrolizumab Integration},
  journal = {Cancer Management and Research},
  year = {2026},
  volume = {Volume 18},
  pages = {1--18},
  doi = {10.2147/cmar.s653901}
}
Kostenlos starten →